Public Relations

Ranbaxy to launch generic version of Flomax next year

Pharma company Ranbaxy Laboratories today said it will launch a generic version of the urinary disorder treatment drug-- Flomax, next year. - Fortis in talks to buy Lanka hospital chain - Ranbaxy exits generic drugs JV with Japanese firm - Japan"s largest drug maker Takeda plans India foray - Sunny re-rating of pharma companies - "We are moving towards a larger addressable market" - Avon to gain from nod to Ranbaxy"s drug "We will launch a generic version of the urinary disorder treatment Flomax in March 2010," Ranbaxy Laboratories CFO Omesh Sethi told reporters on the sidelines of a seminar here. "We would launch another big one in 2014," he said, without naming it. "We are doing well and expect a good revenue from domestic and global markets in the next financial year," Sethi said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Industries owe Rs 220 cr to power distribution companies
The industrial consumers numbering 19,417 owed Rs 220.15 crore as outstanding electricity bill to the power distribution companies in the state.
Popular Articles

Glenmark, Medicis sign two agreements
Glenmark Pharmaceuticals today announced two significant agreements with US-based Medicis Pharmaceutical Corporation.

United Europe: A distant dream
It is towards Ireland that all eyes in Brussels, the headquarters of the European Union, are currently trained. On October 2 the Irish will hold a referendum for the second time to decide whether or not to approve the Lisbon Treaty. The island-nation will thus decide the fate of a much beleaguered set of proposed changes to the 27-member EU’s rule book that has its opponents frothing at the mouth even as its supporters tout its transformational potential.